
Search Results for compounds
Searching compounds for 10103-46-5 returned 1332 results.
Did you mean 1,10 4,6 5?
Displaying compounds 726 - 750 of 1332 in total
T3D2249
58802-14-5
4,6,10-trichloro-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2,4,6,9,11-hexaene
T3D2338
52025-76-0
10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-2(7),3,5-triene-3,10-diol
T3D2416
74992-97-5
T3D3012
29342-05-0
6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one
Matched description: … is most likely due to inhibition of 5-lipoxygenase and cyclooxygenase. Ciclopirox may exert its …
T3D3082
15920-93-1
2-amino-3-(methylamino)propanoic acid
Matched description: … kainite receptors. The activation of the metabotropic glutamate receptor 5 is believed to induce …
T3D3474
28289-54-5
T3D3903
67747-09-5
T3D4282
68-96-2
(1S,2R,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one
T3D4737
1951-25-3
{2-[4-(2-butyl-1-benzofuran-3-carbonyl)-2,6-diiodophenoxy]ethyl}diethylamine
Matched synonyms: … 2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran …
T3D4781
58-93-5
T3D0831
482-45-1
4-[(3-methylbut-2-en-1-yl)oxy]-7H-furo[3,2-g]chromen-7-one
Matched carcinogenicity: … carcinogenic to humans (Group 1), 5-methoxypsoralen as possibly carcinogenic to humans (Group 2A), and …
Matched treatment: … If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium …
Matched treatment: … If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium …
T3D0836
298-81-7
9-methoxy-7H-furo[3,2-g]chromen-7-one
Matched treatment: … If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium …
Matched synonyms: … 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone ... 8-Methoxy-4',5':6,7-furocoumarin …
Matched synonyms: … 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone ... 8-Methoxy-4',5':6,7-furocoumarin …
T3D2754
132539-06-1
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),5,8,10,12-hexaene
Matched description: … as a pill that comes in the strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg and as as ... Zydis orally disintegrating tablets in the strengths of 5 mg, 10 mg, 15 mg, and 20 mg. It is also …
T3D2802
54910-89-3
methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Matched treatment: … If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium …
Matched description: … stimulation of somatodendritic 5-HT1A and terminal autoreceptors. Chronic use leads to ... desensitization of somatodendritic 5-HT1A and terminal autoreceptors. The overall clinical effect of …
Matched description: … stimulation of somatodendritic 5-HT1A and terminal autoreceptors. Chronic use leads to ... desensitization of somatodendritic 5-HT1A and terminal autoreceptors. The overall clinical effect of …
T3D0067
33213-65-9
(1R,9S)-1,9,10,11,12,12-hexachloro-4,6-dioxa-5λ⁴-thiatricyclo[7.2.1.0²,⁸]dodec-10-en-5-one
T3D0310
98-05-5
T3D0341
1344-48-5
T3D0346
12068-90-5
T3D0524
52744-13-5
T3D0548
39635-35-3
T3D1234
18282-10-5
T3D1311
593-89-5
T3D1426
12082-08-5
T3D1469
12179-14-5